Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 25;11(11):395.
doi: 10.21037/atm-23-1719. Epub 2023 Aug 18.

Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implications

Ovidiu Vornicu  1   2 , Emily Perriens  3 , Sydney Blackman  3 , Elina Smoos  4 , Christophe Al Sammour  4 , Ilann Oueslati  4 , Alexis Philippot  4 , David Vidal Bankier  4 , Charbel Haddad  4 , Maha Bendoumou  4 , Tom François  4 , Isabelle Michaux  1 , Anne-Sophie Dincq  1   2 , Patrick Evrard  1 , Pierre Bulpa  1 , Patrick M Honore  1
Affiliations
Editorial

Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implications

Ovidiu Vornicu et al. Ann Transl Med. .
No abstract available

Keywords: 28 days mortality; Severe community-acquired pneumonia (severe CAP); hydrocortisone; implications for clinicians; septic shock excluded.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-23-1719/coif). The authors have no conflicts of interest to declare.

Comment on

  • Hydrocortisone in Severe Community-Acquired Pneumonia.
    Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, Reignier J, Heming N, Plantefève G, Souweine B, Voiriot G, Colin G, Frat JP, Mira JP, Barbarot N, François B, Louis G, Gibot S, Guitton C, Giacardi C, Hraiech S, Vimeux S, L'Her E, Faure H, Herbrecht JE, Bouisse C, Joret A, Terzi N, Gacouin A, Quentin C, Jourdain M, Leclerc M, Coffre C, Bourgoin H, Lengellé C, Caille-Fénérol C, Giraudeau B, Le Gouge A; CRICS-TriGGERSep Network. Dequin PF, et al. N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21. N Engl J Med. 2023. PMID: 36942789 Clinical Trial.

References

    1. Dequin PF, Meziani F, Quenot JP, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med 2023;388:1931-41. 10.1056/NEJMoa2215145 - DOI - PubMed
    1. Taher A, Lashkari M, Keramat F, et al. Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial. Wien Med Wochenschr 2023;173:140-51. 10.1007/s10354-022-00993-4 - DOI - PMC - PubMed
    1. Martin-Loeches I, Torres A. Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm? Eur Respir Rev 2021;30:200346. 10.1183/16000617.0346-2020 - DOI - PMC - PubMed
    1. Kegler SR, Baldwin GT, Rudd RA, et al. Increases in United States life expectancy through reductions in injury-related death. Popul Health Metr 2017;15:32. 10.1186/s12963-017-0150-4 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Pneumonia. Available online: www.cdc.gov/nchs/fastats/pneumonia.htm